Wales Cancer Partnership Translational Research Committee (TReC)
The Translational Research Committee (TReC) is a pool of expertise available to the South Wales cancer research community on the 'bench-to-bedside' therapeutic pipeline. Its purpose is to increase the rate of translation of new therapeutic approaches (either with new treatments, new combinations or repurposed treatments) from the lab to phase I trials. It is accessible to all who hope to see their work go forward into a new clinical approach.
Those who are working up an application to submit to a funding committee are particularly encouraged to take advantage of the committee. The TReC aims to provide a friendly review prior to formal submission.
Applicants will be asked to fill in a form online which will be reviewed.
- Applicants to the TReC will then be matched with relevant expertise on the panel, who can provide informal mentorship until the project is ready to be presented.
- The TReC will also circulate opportunities for funding, often overlooked, e.g. from drug companies.
- The committee will meet 3-4 times per year.
To register your project with the TReC, please complete the application form here.
To view open funding calls, visit the ECMC Combinations Alliance page here.